Obesity Reduces Mortality in Advanced Prostate Cancer labroots.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from labroots.com Daily Mail and Mail on Sunday newspapers.
Share:
Data Includes First Real World Evidence on Alternating Bladder EpiCheck® and Cystoscopy for Surveillance of Non-Muscle Invasive Bladder Cancer (NMIBC)
Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced data from two abstracts featuring its Bladder EpiCheck® test at the 36th Annual European Association of Urology (EAU) Virtual Congress.
The first abstract titled, Real world evidence of alternating cystoscopy/cytology with Bladder EpiCheck in NMIBC surveillance, shows the results of a pilot performed at Radboud University Medical Center evaluating the feasibility and clinical outcomes of alternating between cystoscopy/cytology and Bladder EpiCheck in non-muscle invasive bladder cancer (NMIBC) surveillance. To alleviate the burden of invasive and costly standard surveillance methods on patients, urine collection was performed at home and shipped to a central lab to perform the Bladder EpiCheck test. In the pi
Data Includes First Real World Evidence on Alternating Bladder EpiCheck® and Cystoscopy for Surveillance of Non-Muscle Invasive Bladder Cancer (NMIBC)
Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced data from two abstracts featuring its Bladder EpiCheck® test at the 36th Annual European Association of Urology (EAU) Virtual Congress.
The first abstract titled, “Real world evidence of alternating cystoscopy/cytology with Bladder EpiCheck in NMIBC surveillance,” shows the results of a pilot performed at Radboud University Medical Center evaluating the feasibility and clinical outcomes of alternating between cystoscopy/cytology and Bladder EpiCheck in non-muscle invasive bladder cancer (NMIBC) surveillance. To alleviate the burden of invasive and costly standard surveillance methods on patients, urine collection was performed at home and shipped to a central lab to perform the Bladder EpiCheck test. In the pilot
EAU 2014 - Debate: Surgical treatment of muscle invasive bladder cancer: Cost comparison analysis - Session Highlights
STOCKHOLM, SWEDEN (UroToday.com) - Dr. R. Gaston presented the pro-side of the debate in favor of robotic-assisted radical cystectomy (RARC).
The EAU guidelines state that RARC does not improve oncologic outcomes, rather surgical expertise does (Grade A recommendation). In retrospective series, complication rates are comparable between open and robotic cystectomy (ranging from 11-50%). In a number of small series, no significant difference in positive surgical margin rate and lymph node yield has been demonstrated between RARC and open cystectomy (OC). At least one small prospective randomized-controlled trial has confirmed the non-inferiority of RARC to ORC.